CHICAGO, Sept. 14, 2017 -- Allscripts (NASDAQ:MDRX) is delivering an innovative first-to-market workflow solution that empowers clinicians and patients with complete information, at the point of care and in real time, to optimize the clinical and financial impact of prescription workflow. Allscripts is the first major healthcare information technology supplier to deliver such a solution.
Allscripts Real-Time Health System (RTHS) is launching a journey toward next-level patient care. The conceptual initiative aims to work with partner companies to enable technology that will deliver real-time information on:
- The medication price from the health plan or pharmacy benefit manager (PBM)
- The cash price
- What alternative therapies and their cost
- Competitive prices at different pharmacies
With multiple Payer/PBM and technology partners, Allscripts will focus on automatically embedding real-time prescription pricing information into the prescribing workflow, enabling healthcare providers to see what patients will pay for their medication at the point of care. Providers can then choose to communicate various savings methods and discounts based on their patients’ needs, increasing consumer knowledge and satisfaction, and improving the likelihood of medication adherence.
“This initiative ensures that physicians and their patients will have full knowledge of the price of medications and discounts available to them,” said Allscripts Senior Vice President and General Manager of Payer and Life Sciences, Jay Bhattacharyya. “Our recent partnerships with DrFirst, GoodRx and Surescripts give our providers coverage for nearly 100% of their patients and puts Allscripts at the forefront of delivering real-time benefit and price information, directly at the point of care.”
About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2017 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact:
Investors:
Seth Frank
312-506-1213
[email protected]
Media:
Concetta Rasiarmos
312-447-2466
[email protected]


Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



